Theresa Gourde, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 10623 S Redwood Rd, Suite 101, South Jordan, UT 84095 Phone: 801-302-0899 Fax: 801-302-0892 |
Dr. Forrest A Bullock, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5268 W Bowstring Way, South Jordan, UT 84009 Phone: 307-760-3869 |
Dr. Rachot K Vacharothone, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10464 S Redwood Rd, South Jordan, UT 84095 Phone: 801-260-1919 Fax: 801-260-1441 |
Dr. Brigham Ronald Smith, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5126 W Daybreak Pkwy, South Jordan, UT 84009 Phone: 801-213-4500 |
Martin A Hollingsworth, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3556 W 9800 S, #101, South Jordan, UT 84095 Phone: 801-567-9750 Fax: 801-567-9826 |
Patricia Legant, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5126 W Daybreak Parkway, South Jordan Medical Center, South Jordan, UT 84095 Phone: 801-213-4319 |
News Archive
Acculis Limited today announced the regulatory clearance of its revolutionary new device for destroying unwanted tissues, such as liver tumours. The clearance under the European CE Mark system allows the company to begin deliveries for treating patients throughout Europe and elsewhere where the CE Mark system is recognised. The device is a single high power high frequency 2.45GHz microwave needle that burns a 5cm sphere of tissue in just 5 minutes which is between 3 to 10 times faster than old school radiofrequency based systems or lower frequency 915MHz microwave systems.
Almost all Canadian parents (92%) are concerned about sun protection for their children, a new survey for the Canadian Dermatology Association (CDA) shows.
New research led by UCD Conway Fellow, Professor Johan Ericsson has identified a key regulator of fat cell differentiation that may be a novel target for obesity drugs. The results of the research are published in the current edition of the scientific journal, Proceedings of the National Academy of Sciences (PNAS).
A study led by UCLA tested a new performance intervention to help improve adherence to national guideline-recommended therapies for heart failure patients in an outpatient setting.
Kinetic Muscles Inc., a leading innovator of neurorehabilitation technology, announced it has received a 2-year Phase II SBIR grant to study a new treatment for veterans returning from active duty with traumatic brain injury.
› Verified 3 days ago